FDA OKs Octreotide Capsules; COVID-19 Damages Endocrine System

(MedPage Today) -- The FDA approved octreotide (Mycapssa) capsules for long-term maintenance of acromegaly in those already treated with octreotide or lanreotide, Chiasma announced.
Certain medication and medical devices may inadvertently expose...